Browse CATs

Browse CATs  internal medicine  cardiology  tachyarrhythmias

Diagnosis Economics Harm/ aetiology Prognosis Therapy Supraventricular Ventricular

Cardiac Arrest post-arrest: implantable defibrillators reduced mortality. Level of evidence 1b Expiry Date October 2003 Cardiac arrest implantable cardioverter defibrillators were not clearly more effective than amiodarone. Level of evidence 1b Expiry Date October 2004 Heart failure myocardial infarction: amiodarone reduces mortality Level of evidence 1a Expiry Date July 2003 Myocardial infarction selective lidocaine was not clearly better than prophylactic lidocaine. Level of evidence 1b- Expiry Date October 2004 Myocardial infarction thrombolysis: increased tachyarrhythmias in general, but decreased VF. Level of evidence 1a Expiry Date January 2004 Myocardial infarction d-sotalol may have increased death. Level of evidence 1b Expiry Date October 2004 Myocardial infarction arrhythmias: encainide and flecainide increased the risk of dying. Level of evidence 1b Expiry Date December 2004 Myocardial infarction arrhythmia: flecainide and encainide increased the risk of death. Level of evidence 1b Expiry Date January 2004 Tachycardia sotalol decreased implantable-defibrillator first shocks. Level of evidence 1b Expiry Date January 2004 Tachycardia implanted defibrillators decreased death. Level of evidence 1b Expiry Date August 2004 Tachycardia Implantable atrioverters converted rhythm safely. Level of evidence 2c Expiry Date October 2004 Tachycardia Implantable cardioverter defibrillators clearly decreased mortality. Level of evidence 1b Expiry Date August 2004 Tachycardia Metoprolol was better than sotalol at decreasing the likelihood of recurrence Level of evidence 1b Expiry Date August 2004 Tachycardia subendocardial resection and endoaneurysmorrhaphy was effective. Level of evidence 4 Expiry Date October 2004 Tachycardia high dose intravenous amiodarone was safe and efficacious. Level of evidence 1b Expiry Date October 2004 Tachycardia defibrillators implanted with endocardial leads decreased mortality. Level of evidence 2b Expiry Date October 2004 Tachycardia Implantable defibrillators decreased death. Level of evidence 1b Expiry Date October 2004 Tachycardia electrophysiologically guided therapy had no clear benefit. Level of evidence 1b- Expiry Date October 2004 Ventricular tachyarrhythmia electrophysiologic testing was no better than Holter monitoring at determining treatment. Level of evidence 1b Expiry Date October 2004